International Stem Cell (ISCO) EBITDA (2010 - 2026)
International Stem Cell's EBITDA came in at -$7,000 for Q2 2026, compared with $221,000 a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) EBITDA (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, International Stem Cell reported EBITDA of $105,000, down 18.6% year-over-year; for FY2025, it came in at -$48,000.
- Going back by year, EBITDA was $138,000 in FY2024, -$469,000 in FY2023, $35,000 in FY2022 and -$1.66 million in FY2021.
- The five-year range for quarterly EBITDA is -$558,000 (Q3 2021) to $221,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | International Stem Cell | 2.80 Mn | -1.17 Mn | 1.46 Mn | -7,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7,000.00 |
| Dec 31, 2025 | -259,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 221,000.00 |
| Mar 31, 2025 | -160,000.00 |
| Dec 31, 2024 | 105,000.00 |
| Sep 30, 2024 | -37,000.00 |
| Jun 30, 2024 | 199,000.00 |
| Mar 31, 2024 | -129,000.00 |
| Dec 31, 2023 | -376,000.00 |
| Sep 30, 2023 | -50,000.00 |
| Jun 30, 2023 | -96,000.00 |
| Mar 31, 2023 | 53,000.00 |
| Dec 31, 2022 | 113,000.00 |
| Sep 30, 2022 | -245,000.00 |
| Jun 30, 2022 | 86,000.00 |
| Mar 31, 2022 | 81,000.00 |
| Dec 31, 2021 | -256,000.00 |
| Sep 30, 2021 | -558,000.00 |
| Jun 30, 2021 | -342,000.00 |
API Access
International Stem Cell EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();